A Clinical study to compare induced emesis(vomitting) effect of medicine like Madanaphala and Jimutaka in skin disease (psoriasis)

A comparitive clinical study of Madanaphala and Jimutaka yoga in the management of Eka kushta w.s.r Psoriasis

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/07/020266

Enrollment

Registered

2019-07-19

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L400- Psoriasis vulgaris

Interventions

Intervention1: Madana Phala: Drug-Madanaphala Part used: pippali Dosage: 12grms Sahapan with Honey As a vamak yoga duration-10days Control Intervention1: Jimutaka: Drug: Jimutaka Part used: fruit Dos

Eligibility

Inclusion criteria

Inclusion criteria: Inclusion Criteria Patients indicated for Vamana. Age group between 18-60 yrs of either gender. Patient having the classical sign & symptoms of Ek-kushta. Patients having Madhyam kostha

Exclusion criteria

Exclusion criteria: Patients below 18 and above 60 years. Psoriasis associated with other systemic disorder.

Design outcomes

Primary

Measure	Time frame
Relieve in the symptoms of psoriasisTimepoint: 1 Month	—

Secondary

Measure	Time frame
relieve in the symptoms of psoriasisTimepoint: 1 month	—

Countries

India

Contacts

Public ContactMd Imtiaz Hossain

Parul Institute Of Ayurved

amolpatane@gmail.com9607175173

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026